And do the benefits outweigh the risk because no medication is without side effects
In respect to their cardiovascular effects among patients with T2DM, both GLP-1RAs and SGLT2is have been shown to reduce the risk of MACE (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke), with GLP-1RAs reducing the risk of non-fatal stroke to a greater extent [3, 6]
At Meeting Point Health, we prioritize transparency, ensuring that all potential benefits and risks are thoroughly discussed with every patient before beginning a protocol
If you experience constipation, make sure you are drinking plenty of fluids and contact your doctor for advice
We know that for these patients with obesity, diabetes, CKD, cardiovascular disease [CVD], these are really not isolated or distinct entities. However, the research comes at a time when supply chain issues for the GLP-1 receptor agonists have been pronounced and prolonged
In further tests, the rodents also appeared less susceptible to fatal overdose